Market Access

Latest News

Peter Rubin
How Are Health Plans Impacting Drug Prices?

September 29th 2025

While the MFN executive order targets drug companies for drug prices, Peter Rubin discusses how health plans also play a large role in this area.

Image Credit: Adobe Stock Images/Alex Puhovoy. Image Credit: Adobe Stock Images/Alex Puhovoy. The Most Favored Nation (MFN) proposal would tie US drug prices to the lowest prices paid in other wealthy countries.
Most Favored Nation Drug Pricing Undermines What Makes America Great

September 26th 2025

Image Credit: Adobe Stock Images/Kassandra. Image Credit: Adobe Stock Images/Kassandra. GLP-1 receptor agonists have been found to deliver bariatric-surgery-level results, with durable benefits and manageable risks.
The Evolution of Obesity Drugs: Lessons from a Century of Failures and the GLP-1 Breakthrough

September 25th 2025

Tim Affeldt
Reducing Costs and Increasing Care for Specialty Patients: Q&A with Tim Affeldt

September 19th 2025

From Lab to Market: Tracking Today’s Shifting Pathways for Biotech
From Lab to Market: Tracking Today’s Shifting Pathways for Biotech

September 17th 2025

Video Interviews

More News

© 2025 MJH Life Sciences

All rights reserved.